66M with Stage IV Pancoast NSCLC — starting Keytruda + Alimta, seeking advice & second-opinion experiences
My dad (66) was recently diagnosed with stage IV NSCLC adenocarcinoma, presenting as a Pancoast tumor. He has lost about 20 lbs, has arm weakness/muscle loss, back pain, and metastatic disease to lymph nodes, lungs, and likely bone (C7). PD-L1 is <1%, and no targetable mutations have been found so far.
His treatment plan is Keytruda + Alimta, with carboplatin possibly being added later. We were told clinical trials are not currently an option because of his functional status.
A few questions:
- If you or a loved one had a similar diagnosis/treatment plan, what do you wish you knew before starting treatment?
- Has anyone with PD-L1 <1% had success with immunotherapy?
- We're considering a second opinion at an NCI-designated center (U of M). Did a second opinion change anything for you, even after treatment had already been started?
- His oncologist does not feel a PET scan is necessary. In a case like this, would you still want one?
We were given a rough prognosis of 18 months to 2 years. I'd appreciate hearing from anyone with a similar experience.